Novartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how patients will respond to new and existing treatments for inflammatory
In the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they're changing medicine, research and development, and healthcare, and how the
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
